Inactive Instrument

News ADVANZ PHARMA Corp. Limited Toronto S.E.

Equities

ADVZ

JE00BJVH6L55

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

ADVANZ PHARMA Corp. Limited announced that it has received funding from Nordic Capital, Ontario Teachers' Pension Plan Board	Feb. 25	CI
ADVANZ PHARMA Corp. Limited signed an agreement to acquire Global rights of Androcur.	Nov. 06	CI
ADVANZ PHARMA Corp. Limited completed the acquisition of Global rights of Tostran from Kyowa Kirin Co., Ltd..	23-10-17	CI
Alvotech and Advanz Pharma Extend Strategic Partnership to Commercialize Five Proposed Biosimilars in Europe	23-05-24	CI
ADVANZ PHARMA Corp. Limited signed an agreement to acquire Global rights of Tostran from Kyowa Kirin Co., Ltd..	23-04-24	CI
Applied Therapeutics, Inc. Announces Partnership with Advanz Pharma for Commercialization of AT-007 in Europe	23-01-04	CI
ADVANZ PHARMA further strengthens its specialty and hospital business by acquiring an anti-infective portfolio from Sanofi	22-10-04	AQ
ADVANZ PHARMA Corp. Limited acquired Portfolio Of Generic Drugs Of Sanofi.	22-10-02	CI
ADVANZ PHARMA to receive exclusive rights from PolyPid to commercialize D-PLEX100 in Europe	22-08-04	AQ
INTERCEPT ANNOUNCES CLOSING OF TRANSACTION WITH ADVANZ PHARMA TO TRANSFER RIGHTS TO COMMERCIALIZE OCALIVA FOR PBC OUTSIDE THE U.S.	22-07-04	AQ
ADVANZ PHARMA completes acquisition of Intercept's business in Europe, Canada, and all other markets outside of the U.S.	22-07-04	AQ
ADVANZ PHARMA Corp. Limited Names Andreas Stickler as New CFO	22-04-01	CI
Steffen Wagner assumes his position as new Chief Executive Officer at ADVANZ PHARMA	22-04-01	AQ
ADVANZ PHARMA Corp. Limited Limited Names Susanna El-Armale as Chief Corporate Development Officer	22-04-01	CI
Steffen Wagner Assumes His Position as New Chief Executive Officer At ADVANZ PHARMA Corp. Limited	22-04-01	CI
ADVANZ PHARMA launches its first Environmental, Social and Governance report	21-12-10	AQ
ADVANZ PHARMA makes key changes to senior leadership to further accelerate next phase of growth	21-11-18	PR
ADVANZ PHARMA Corp. Limited Announces Executive Changes	21-11-18	CI
ADVANZ PHARMA Corp. Limited Announces Executive Changes	21-11-18	CI
ADVANZ PHARMA Corp. Limited Announces Executive Changes	21-11-18	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News ADVANZ PHARMA Corp. Limited Toronto S.E.

Equities

ADVZ

JE00BJVH6L55

Summary

Filters